Tempus AI achieves strong revenue growth and beats expectations, but ongoing losses and execution risks temper enthusiasm.

Tempus AI Inc. (NASDAQ:TEM) reported second-quarter financial results Friday. The AI-focused precision medicine and patient ...

Tempus AI, Inc. (NASDAQ:TEM) investors will be delighted, with the company turning in some strong numbers with its latest results. Results overall were solid, with revenues arriving 5.7% better than ...

The stock of Tempus AI (NASDAQ: TEM) gave back some of its gains after surging early in Friday's trading, but it still ended ...

Q2 2025 Earnings Call Transcript August 8, 2025 Tempus AI, Inc. beats earnings expectations. Reported EPS is $-0.22, expectations were $-0.23. Operator: Thank you for standing by, and welcome to ...

Tempus AI (NASDAQ:TEM) stock sees a 9% pre-market gain as the company raises its 2025 revenue outlook amid strong Q2 ...

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting ...

In a report released today, Rachel Vatnsdal from J.P. Morgan maintained a Hold rating on Tempus AI, Inc. Class A, with a price target of $60.00. The company’s shares closed last Friday at $60.87. Take ...

Tempus AI, Inc. Class A (($TEM)) has held its Q2 earnings call. Read on for the main highlights of the call. Tempus AI, Inc. Class A recently held ...

Although shares have retreated from their all-time high, those who bought shares one year ago are still looking at growth in ...

In trading on the Nasdaq stock market as of 1:17 p.m. Central, Tempus' stock price was trading at $60.65, up 3.2% from the ...

In a report released on August 8, Subbu Nambi from Guggenheim reiterated a Buy rating on Tempus AI, Inc. Class A, with a price target of $75.00. The company’s shares closed last Friday at $60.87.